ChiCTR-TRC-14005054
正在进行
/
/
/
2014-08-05
/
/
White Matter Hyperintensities
抗凝血小板藥物『西洛他唑』用於抑制腦白質體病變之研究
抗凝血小板藥物『西洛他唑』用於抑制腦白質體病變之研究
/
随机平行对照
Ⅳ期
Randomized
Double-blind
General Research Fund
/
140
/
2014-09-01
1990-01-01
/
1) Age 65-85; 2) Chinese ethnicity; 3) Presence of confluent on MRI*; and 4) Written informed consent given；
登录查看1) History of stroke or TIA; 2) Dementia according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition; 3) Presence of peripheral arterial disease that necessitates use of cilostazol; 4) Concurrent use of antiplatelet agents or anticoagulants, e.g. aspirin, clopidogrel, warfarin; 5) Contraindications for use of cilostazol, e.g. heart failure, prior history of allergy to cilostazol; 6) Severe medical illnesses (e.g. malignancy, end-stage renal diseases); 7) Contraindication for MRI (e.g. claustrophobia, metallic implants).；
登录查看The Chinese University of Hong Kong
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
